| Gene symbol | MAGEC2 | Synonyms | CT10, HCA587, MAGEE1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq27.2 | dbXrefs | |
| Description | MAGE family member C2 | ||||
| GTO ID | GTC2581 |
| Trial ID | NCT04729543 |
| Disease | Melanoma | Head and Neck Cancer |
| Altered gene | MAGE-C2 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | MAGE-C2 TCR-T cells |
| HLA | HLA-A*02:01 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Adoptive Therapy With TCR Gene-engineered T Cells to Treat Patients With MAGE-C2-positive Melanoma and Head and Neck Cancer |
| Year | 2020 |
| Country | Netherlands |
| Company sponsor | Erasmus Medical Center |
| Other ID(s) | NL69011.000.19 |
| Cohort 1 | |||||||||||
|
|||||||||||